Initiated the Phase 3 VELA program of the Nanobody® sonelokimab in patients with moderate-to-severe hidradenitis suppurativa (HS) and the Phase 3 ...

SI-BONE (NASDAQ:SIBN – Free Report) had its target price increased by Needham & Company LLC from $20.00 to $24.00 in a research report released on Tuesday morning,Benzinga reports. The brokerage ...

I spoke to one of the passionate green enthusiasts, Bex Claire Hamell, about the Philadelphia Flower Show and planting roots.